#ASH17: Blue­print el­bows its way to cen­ter ring with ear­ly da­ta and a plan to seek quick FDA OK

Blue­print Med­i­cines $BPMC jumped on­to the radar at ASH on Sun­day, out­lin­ing some re­mark­able da­ta on their lead drug as the biotech lays the foun­da­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.